Anne Johnson joined atai Life Sciences in 2021 as Vice President, Global Controller.

Previously, Anne was a Controller at Aruvant, an International Biotechnology Company, focusing on gene therapies for rare diseases. Prior to this, she has held a number of senior leadership roles within the CFO office, include Corporate Controller at Chimerix, Inc and VP Finance at Xanodyne Pharmaceuticals.

She holds a B.Sc in Accounting from the University of North Carolina at Wilmington and is an AICPA qualified accountant.